<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
KYMR
Kymera Therapeutics
$
()


  • Kymera Therapeutics announces FDA clearance of IND application for KT-621

    Today - 07:03am
  • Kymera Therapeutics price target raised by $4 at Oppenheimer, here's why

    9/27/2024 - 07:34am
  • Kymera Therapeutics presents data for KT-621 at EADV Congress

    9/25/2024 - 07:02am
  • Kymera assumed with Outperform from Market Perform at Leerink

    9/9/2024 - 06:21am
  • What You Missed On Wall Street On Monday

    8/26/2024 - 16:09pm
  • Boeing's Starliner to return without astronauts: Morning Buzz

    8/26/2024 - 12:03pm
  • Kymera upgraded, MoonLake downgraded: Wall Street's top analyst calls

    8/26/2024 - 09:32am
  • Wolfe upgrades Kymera Therapeutics, calls 'great long-term trade'

    8/26/2024 - 06:09am
  • Wolfe Research gets more bullish on Kymera Therapeutics, upgrades shares

    8/26/2024 - 05:28am
  • Morning Movers: Lowe's moves lower after guidance cut

    8/20/2024 - 08:54am
  • Kymera Therapeutics $200M Spot Secondary re-offered at $40.75

    8/19/2024 - 16:21pm
  • Kymera Therapeutics announces $200M common stock offering

    8/19/2024 - 16:03pm
  • Kymera Therapeutics price target raised by $11 at Morgan Stanley, here's why

    8/14/2024 - 06:51am
  • Kymera Therapeutics price target raised by $8 at Wells Fargo, here's why

    8/12/2024 - 06:23am
  • Kymera Therapeutics price target raised by $14 at H.C. Wainwright, here's why

    8/8/2024 - 06:23am
dynamic_feed Breaking News